Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Thomas J. Esparza, Yaozong Chen, Negin P. Martin, Helle Bielefeldt-Ohmann, Richard A. Bowen, William D. Tolbert, Marzena Pazgier & David L. Brody. (2022) Nebulized delivery of a broadly neutralizing SARS-CoV-2 RBD-specific nanobody prevents clinical, virological, and pathological disease in a Syrian hamster model of COVID-19. mAbs 14:1.
Read now
Read now
Articles from other publishers (15)
Suraj H. Shinde, Sandeep & Abhay H. Pande. (2024) Polyvalency: an emerging trend in the development of clinical antibodies. Drug Discovery Today 29:1, pages 103846.
Crossref
Crossref
Minchuan Zhang, Kong-Peng Lam & Shengli Xu. (2023) Natural Killer Cell Engagers (NKCEs): a new frontier in cancer immunotherapy. Frontiers in Immunology 14.
Crossref
Crossref
Zhifang Yang, Chuang Wang, Jia Liu, Lan Xiao, Lei Guo & Jianwei Xie. (2023) In Silico–Ex Vitro Iteration Strategy for Affinity Maturation of Anti-Ricin Peptides and the SPR Biosensing Application. Toxins 15:8, pages 490.
Crossref
Crossref
Eugene M. Obeng, Alex J. Fulcher & Kylie M. Wagstaff. (2023) Harnessing sortase A transpeptidation for advanced targeted therapeutics and vaccine engineering. Biotechnology Advances 64, pages 108108.
Crossref
Crossref
Guifang Xie, Ying Lu, Wenkai Li, Zhenyun He, Zhichang Sun, Xiaoxia Xie & Xing Liu. (2022) Simultaneous heptamerization of nanobody and alkaline phosphatase by self-assembly and its application for ultrasensitive immunodetection of small molecular contaminants in agro-products. Food Control 141, pages 109156.
Crossref
Crossref
Simone C. Oostindie, Greg A. Lazar, Janine Schuurman & Paul W. H. I. Parren. (2022) Avidity in antibody effector functions and biotherapeutic drug design. Nature Reviews Drug Discovery 21:10, pages 715-735.
Crossref
Crossref
Eugene M. Obeng, Isaac Fianu & Michael K. Danquah. (2022) Multivalent ACE2 engineering—A promising pathway for advanced coronavirus nanomedicine development. Nano Today 46, pages 101580.
Crossref
Crossref
Jack Wade, Charlotte Rimbault, Hanif Ali, Line Ledsgaard, Esperanza Rivera-de-Torre, Maher Abou Hachem, Kim Boddum, Nadia Mirza, Markus-Frederik Bohn, Siri A. Sakya, Fulgencio Ruso-Julve, Jan Terje Andersen & Andreas H. Laustsen. (2022) Generation of Multivalent Nanobody-Based Proteins with Improved Neutralization of Long α-Neurotoxins from Elapid Snakes. Bioconjugate Chemistry 33:8, pages 1494-1504.
Crossref
Crossref
Kathryn M. Hastie, Haoyang Li, Daniel Bedinger, Sharon L. Schendel, S. Moses Dennison, Kan LiVamseedhar Rayaprolu, Xiaoying Yu, Colin Mann, Michelle Zandonatti, Ruben Diaz AvalosDawid Zyla, Tierra Buck, Sean HuiKelly ShafferChitra Hariharan, Jieyun Yin, Eduardo OlmedillasAdrian Enriquez, Diptiben Parekh, Milite Abraha, Elizabeth Feeney, Gillian Q. Horn, Yoann Aldon, Hanif Ali, Sanja Aracic, Ronald R. CobbRoss S. FedermanJoseph M. Fernandez, Jacob GlanvilleRobin Green, Gevorg Grigoryan, Ana G. Lujan Hernandez, David D. Ho, Kuan-Ying A. Huang, John Ingraham, Weidong Jiang, Paul Kellam, Cheolmin Kim, Minsoo KimHyeong Mi KimChao KongShelly J. Krebs, Fei LanGuojun LangSooyoung Lee, Cheuk Lun LeungJunli Liu, Yanan LuAnna MacCamy, Andrew T. McGuire, Anne L. Palser, Terence H. Rabbitts, Zahra Rikhtegaran Tehrani, Mohammad M. Sajadi, Rogier W. Sanders, Aaron K. SatoLiang Schweizer, Jimin Seo, Bingqing Shen, Jonne L. SnitselaarLeonidas Stamatatos, Yongcong TanMilan T. Tomic, Marit J. van Gils, Sawsan YoussefJian Yu, Tom Z. Yuan, Qian Zhang, Bjoern Peters, Georgia D. Tomaras, Timothy Germann & Erica Ollmann Saphire. (2021) Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study. Science 374:6566, pages 472-478.
Crossref
Crossref
Ami Miller, Adam Leach, Jemima Thomas, Craig McAndrew, Emma Bentley, Giada Mattiuzzo, Lijo John, Ali Mirazimi, Gemma Harris, Nadisha Gamage, Stephen Carr, Hanif Ali, Rob Van Montfort & Terence Rabbitts. (2021) A super-potent tetramerized ACE2 protein displays enhanced neutralization of SARS-CoV-2 virus infection. Scientific Reports 11:1.
Crossref
Crossref
Adam Leach, Ami Miller, Emma Bentley, Giada Mattiuzzo, Jemima Thomas, Craig McAndrew, Rob Van Montfort & Terence Rabbitts. (2021) Implementing a method for engineering multivalency to substantially enhance binding of clinical trial anti-SARS-CoV-2 antibodies to wildtype spike and variants of concern proteins. Scientific Reports 11:1.
Crossref
Crossref
Yunxiang Huang, Jinheng Fu, Yinfeng Zhong, Wenyuan Shuai, Hang Zhang, Yanping Li, Qinghua He & Zhui Tu. (2021) Tandem nanobody: A feasible way to improve the capacity of affinity chromatography. Journal of Chromatography B 1173, pages 122678.
Crossref
Crossref
Alejandro F. Prado, Rose I. M. Batista, Jose E. Tanus-Santos & Raquel F. Gerlach. (2021) Matrix Metalloproteinases and Arterial Hypertension: Role of Oxidative Stress and Nitric Oxide in Vascular Functional and Structural Alterations. Biomolecules 11:4, pages 585.
Crossref
Crossref
Robby Divine, Ha V. Dang, George Ueda, Jorge A. Fallas, Ivan Vulovic, William Sheffler, Shally Saini, Yan Ting ZhaoInfencia Xavier Raj, Peter A. Morawski, Madeleine F. Jennewein, Leah J. Homad, Yu-Hsin Wan, Marti R. TooleyFranziska SeegerAli EtemadiMitchell L. Fahning, James Lazarovits, Alex Roederer, Alexandra C. Walls, Lance Stewart, Mohammadali Mazloomi, Neil P. King, Daniel J. Campbell, Andrew T. McGuire, Leonidas Stamatatos, Hannele Ruohola-Baker, Julie Mathieu, David Veesler & David Baker. (2021) Designed proteins assemble antibodies into modular nanocages. Science 372:6537.
Crossref
Crossref
Jinheng Fu, Yunxiang Huang, Yinfeng Zhong, Wenyuan Shuai, Hang Zhang, Yanping Li, Qinghua He & Zhui Tu. (2021) Tandem Nanobody: A Feasible Way to Improve the Capacity of Affinity Purification. SSRN Electronic Journal.
Crossref
Crossref